NYSE:NVOPharmaceuticals
Assessing Novo Nordisk (NYSE:NVO) After A 47% One-Year Share Price Pullback
If you are wondering whether Novo Nordisk's current share price really reflects what you are getting for your money, this article walks through the numbers so you can judge the value story for yourself.
After touching a last close of US$38.83, the stock has seen mixed returns, with a 0.9% gain over 7 days but declines of 21.3% over 30 days, 25.9% year to date, and 47.0% over 1 year. The 5 year return stands at 15.0%.
Recent coverage of Novo Nordisk has focused heavily on its role in the...